ALGID Fundamental Analysis - EGIDE

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALGID. ALGID was compared to 52 industry peers in the Electronic Equipment, Instruments & Components industry. ALGID may be in some trouble as it scores bad on both profitability and health. ALGID is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALGID had negative earnings in the past year.

ALGID had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: ALGID reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: ALGID reported negative operating cash flow in multiple years.

1.2 Ratios

ALGID's Return On Assets of -9.81% is on the low side compared to the rest of the industry. ALGID is outperformed by 82.69% of its industry peers.

Looking at the Return On Equity, with a value of -35.91%, ALGID is doing worse than 76.92% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-9.81%
ROE	-35.91%
ROIC	N/A

ROA(3y)-13.63%

ROA(5y)-7.33%

ROE(3y)-55.38%

ROE(5y)-31.02%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALGID has a better Gross Margin (65.40%) than 88.46% of its industry peers.

In the last couple of years the Gross Margin of ALGID has remained more or less at the same level.

ALGID does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	65.4%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALGID has more shares outstanding

ALGID has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that ALGID is in the distress zone and has some risk of bankruptcy.

ALGID's Altman-Z score of 1.25 is on the low side compared to the rest of the industry. ALGID is outperformed by 76.92% of its industry peers.

ALGID has a Debt/Equity ratio of 0.82. This is a neutral value indicating ALGID is somewhat dependend on debt financing.

The Debt to Equity ratio of ALGID (0.82) is worse than 75.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Altman-Z	1.25

ROIC/WACCN/A

WACC6.61%

2.3 Liquidity

A Current Ratio of 1.61 indicates that ALGID should not have too much problems paying its short term obligations.

ALGID has a Current ratio (1.61) which is comparable to the rest of the industry.

A Quick Ratio of 0.80 indicates that ALGID may have some problems paying its short term obligations.

ALGID has a Quick ratio of 0.80. This is in the lower half of the industry: ALGID underperforms 75.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.61
Quick Ratio	0.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.96% over the past year.

Looking at the last year, ALGID shows a very negative growth in Revenue. The Revenue has decreased by -18.27% in the last year.

The Revenue has been growing by 28.35% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)28.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%56.65%

Revenue 1Y (TTM)-18.27%

Revenue growth 3Y28.35%

Revenue growth 5YN/A

Sales Q2Q%-16.84%

3.2 Future

The Earnings Per Share is expected to decrease by -25.99% on average over the next years. This is quite bad

ALGID is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.

EPS Next Y-41.48%

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue Next Year22.46%

Revenue Next 2Y-1.63%

Revenue Next 3Y0.68%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALGID. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 9.42, the valuation of ALGID can be described as reasonable.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALGID indicates a rather cheap valuation: ALGID is cheaper than 80.77% of the companies listed in the same industry.

When comparing the Price/Forward Earnings ratio of ALGID to the average of the S&P500 Index (36.59), we can say ALGID is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.42

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as ALGID's earnings are expected to decrease with -25.99% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALGID does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EGIDE

EPA:ALGID (11/27/2025, 7:00:00 PM)

0.39

-0.02 (-4.18%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)10-20 2025-10-20

Earnings (Next)04-27 2026-04-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap7.65M

Revenue(TTM)30.01M

Net Income(TTM)-2.38M

Analysts86.67

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.42
P/S	0.25
P/FCF	N/A
P/OCF	N/A
P/B	1.16
P/tB	1.16
EV/EBITDA	N/A

EPS(TTM)-0.13

EYN/A

EPS(NY)0.04

Fwd EY10.62%

FCF(TTM)-0.09

FCFYN/A

OCF(TTM)-0.08

OCFYN/A

SpS1.53

BVpS0.34

TBVpS0.34

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.81%
ROE	-35.91%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	65.4%
FCFM	N/A

ROA(3y)-13.63%

ROA(5y)-7.33%

ROE(3y)-55.38%

ROE(5y)-31.02%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5YN/A

F-Score4

Asset Turnover1.24

Health

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	20.64%
Cap/Sales	0.96%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.61
Quick Ratio	0.8
Altman-Z	1.25

F-Score4

WACC6.61%

ROIC/WACCN/A

Cap/Depr(3y)34.7%

Cap/Depr(5y)225.04%

Cap/Sales(3y)2%

Cap/Sales(5y)3.91%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)28.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%56.65%

EPS Next Y-41.48%

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.27%

Revenue growth 3Y28.35%

Revenue growth 5YN/A

Sales Q2Q%-16.84%

Revenue Next Year22.46%

Revenue Next 2Y-1.63%

Revenue Next 3Y0.68%

Revenue Next 5YN/A

EBIT growth 1Y26.54%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-6276.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-462.88%

OCF growth 3YN/A

OCF growth 5YN/A

EGIDE / ALGID.PA FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

ChartMill assigns a fundamental rating of 2 / 10 to ALGID.PA.

What is the valuation status for ALGID stock?

ChartMill assigns a valuation rating of 2 / 10 to EGIDE (ALGID.PA). This can be considered as Overvalued.

Can you provide the profitability details for EGIDE?

EGIDE (ALGID.PA) has a profitability rating of 2 / 10.

EGIDE (ALGID.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EGIDE / ALGID.PA FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

What is the valuation status for ALGID stock?

Can you provide the profitability details for EGIDE?